12th Annual Update in Liver & Gastrointestinal Diseases
In-Person Event
Jul 27 - 28, 2018
Clearwater Beach, Florida, USA
OVERVIEW
12th Annual Update in Liver & Gastrointestinal Diseases is organized by University of Florida Health (UF Health) and will be held from Jul 27 - 28, 2018 at Opal Sands Resort, Clearwater Beach, Florida, United States of America.
The target audience for this medical event is educational needs of Internists, Gastroenterologists, Hepatologists, Surgeons, Nurses, Residents and Fellows in the management of different liver and gastrointestinal diseases. This CME Conference has been approved for a maximum of 7 AMA PRA Category 1 Credits.
Conference Objectives
At the conclusion of this conference, attendees should be able to:
• Discuss the current and future therapeutic advances and the role of response-guided therapy in the treatment of Hepatitis C.
• Describe the New CDC Recommendations for HCV Screening.
• Implement state-of-the-art advances in the management of viral hepatitis, cirrhosis and screening of hepatocellular carcinoma.
• Recognize new innovations in endoscopic submucosal dissection.
• Explain recent therapies for liver cancer including immunotherapy, hormone therapy, chemotherapy and radiation therapy.
• Identify distinctive and effective clinical management strategies of inflammatory bowel disease.
• Discuss current and emerging evidence based treatment strategies in liver transplantation.
• Comprehend new information on the advances in portal hypertension and fatty liver disease.
• Discuss the new advances in chronic pancreatitis.
• Describe use of EUS as an interventional tool.
Additional details will be posted as soon as they are available.
The target audience for this medical event is educational needs of Internists, Gastroenterologists, Hepatologists, Surgeons, Nurses, Residents and Fellows in the management of different liver and gastrointestinal diseases. This CME Conference has been approved for a maximum of 7 AMA PRA Category 1 Credits.
Conference Objectives
At the conclusion of this conference, attendees should be able to:
• Discuss the current and future therapeutic advances and the role of response-guided therapy in the treatment of Hepatitis C.
• Describe the New CDC Recommendations for HCV Screening.
• Implement state-of-the-art advances in the management of viral hepatitis, cirrhosis and screening of hepatocellular carcinoma.
• Recognize new innovations in endoscopic submucosal dissection.
• Explain recent therapies for liver cancer including immunotherapy, hormone therapy, chemotherapy and radiation therapy.
• Identify distinctive and effective clinical management strategies of inflammatory bowel disease.
• Discuss current and emerging evidence based treatment strategies in liver transplantation.
• Comprehend new information on the advances in portal hypertension and fatty liver disease.
• Discuss the new advances in chronic pancreatitis.
• Describe use of EUS as an interventional tool.
Additional details will be posted as soon as they are available.
KEY DATES
27 Jul, 2018
Event Start Date
28 Jul, 2018
Event End Date
SPECIALITIES
GastroenterologySUGGESTED HOTELS
CONFERENCE VENUE
Opal Sands ResortRELATED CONFERENCES & LIVE WEBINARS
Quick Links